Where is Vertex Pharmaceuticals headquartered?
Vertex Pharmaceuticals is headquartered in Boston, MA. Its footprint includes major operating, manufacturing, commercial, R&D, laboratory, technology, clinical, or distribution hubs across the United States and international markets.
- HQ
- Boston, MA
- HQ address
- 50 Northern Avenue, Boston, MA 02210
- Offices
- Boston, MA; San Diego, CA; Cambridge, MA; London, UK
- Founded
- 1989
- Employees
- 5,700+
- Largest hub
- Boston, MA
Vertex Pharmaceuticals office locations
Vertex Pharmaceuticals's public footprint includes headquarters and major operating hubs used for executive, commercial, clinical, manufacturing, distribution, laboratory, or technology work.
- Boston, MA· Headquarters
- San Diego, CA· Office
- Cambridge, MA· Office
- London, UK· Office
- Oxford, UK· Office
- Dublin, Ireland· Office
- Toronto, Canada· Office
Sources:Vertex Pharmaceuticals websiteVertex Pharmaceuticals annual reports
Where is Vertex Pharmaceuticals's headquarters?
Vertex Pharmaceuticals's headquarters is listed as Boston, MA, with a public headquarters address of 50 Northern Avenue, Boston, MA 02210. Executive, investor, legal, finance, and enterprise procurement routes are usually tied to this corporate center even when the operational buyer sits elsewhere.
What other offices does Vertex Pharmaceuticals have?
The footprint includes Boston, MA, San Diego, CA, Cambridge, MA, London, UK, Oxford, UK, Dublin, Ireland, Toronto, Canada. For healthcare companies, these locations often split by business-unit leadership, R&D, manufacturing, distribution, commercial teams, technology, clinical operations, laboratory operations, and international market coverage.
What Vertex Pharmaceuticals's office footprint means for territory planning
Territory planning should not treat the headquarters as the only buyer location. Field events and account mapping should follow business-unit hubs, hospital or clinic markets, laboratory and manufacturing nodes, technology centers, and executive travel patterns. Time-zone coverage matters because approvals can involve stakeholders across multiple regions.
As of June 2026.Sources:Vertex Pharmaceuticals websiteVertex Pharmaceuticals annual reportsVertex Pharmaceuticals contact
Vertex Pharmaceuticals — frequently asked questions
